Table 2.
Outcome indicator | Mean values from Likert scale | Regression results | |||||
n = 87 observations | Intervention group | Pre-test | Post-test | Model* | Interaction coefficient † | Standard error | P-value |
1. Perceptions of availability of quality VPD data | Intervention | 2.75 | 3.28 | Linear regression | 0.6533 | 0.4722 | 0.1664 |
Control | 3.00 | 3.18 | |||||
2. Perceived capability to perform analysis of VPD data | Intervention | 3.40 | 3.90 | Linear regression | 1.1191 | 0.3110 | 0.0003 |
Control | 4.50 | 3.80 | |||||
3. Likert scale question measuring motivation to carry out analysis | Intervention | 3.16 | 3.57 | Multinomial regression | -2.4354 | 1.2843 | 0.0579 |
Control | 4.09 | 3.50 | |||||
4. Perceived value of using analyzed VPD data for decision-making | Intervention | 4.08 | 4.09 | Linear regression | 0.2824 | 0.2205 | 0.2004 |
Control | 4.56 | 4.38 | |||||
5. Likert scale question measuring perceived motivation to use surveillance data | Intervention | 3.81 | 3.92 | Multinomial regression | -1.4828 | 1.4084 | 0.2924 |
Control | 4.18 | 3.60 |
VPD = Vaccine preventable disease
*Regression models included: intervention group, subject, survey round, intervention group*survey round interaction term, and controlled for sex, age, years of experience and rayon. Linear and multinomial regression performed using generalized linear model in SAS (Proc Genmod), with generalized estimating equation (GEE) used to account for correlations between subjects with repeated measures.
†Impact of intervention assessed by intervention group*survey round interaction term.